Share

Drug may get rid of dreaded double chin

German drugs giant Bayer said it had launched tests into an injectable drug to combat the fat deposits that lead to the dreaded "double chin".

Bayer said in a statement it was conducting clinical trials into ATX-101, an injectable drug "for the reduction of localised fat under the chin (submental fat)."

The firm is testing some 720 people in 64 centres in Britain, France, Germany, Belgium, Spain and Italy with a view to launching a product in Europe, Asia and South America in 2014.

Jean-Paul Ortonne, a French dermatologist involved in the trials, said: "There is a huge demand for a safe, effective and approved injectable treatment for localised fat reduction."

The tests are a step towards "a well-studied, clinically-proven treatment to reduce localised submental fat without surgery," he added.

Yvonne Moeller, a Bayer spokeswoman, described the procedure as "something like a tattoo".

Between 40 and 70 tiny injections are administered into the fat cells over several sessions, with the amount depending on the size of the double chin and the person, she said.

"You would hope to see noticeable results after about 16 weeks," she added.

(Sapa, January 2011)

Read more:

No knife face lifts

Facial bones not ageless

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE